Strategic Focus Target neuromusculoskeletal technologies with surgeon-driven innovation and focus on devices that improve quality of care, reduce costs, and expand access; potential sales opportunity in portfolio companies and partner networks.

Value Creation Leverage VB track record of over $1.5B in exit value and 200+ transactions to position offerings as accelerants for portfolio exits, appealing to co-investors and strategic buyers seeking proven turnaround and scale.

Global Reach VB portfolio sells products in more than 70 countries; identify localized regulatory, distribution, and service needs to tailor solutions for each market and accelerate international expansion efforts.

Partnership Potential Recent and ongoing partnerships (Plethy integration; Enviro Care ventures) signal openness to collaboration, licensing, and data-driven patient engagement enhancements that can be co-sold or white-labeled.

Portfolio Access VB invests its own capital into ventures and has a broad ecosystem including Paradigm Spine, Centinel Spine, and others; approach by offering complementary technologies, advisory services, and scalable deployment to existing portfolio companies.